Company Overview and News

 
Bajaj Finance hikes FD rates; get up to 9.1% return – Check the details

2018-10-17 financialexpress
Bajaj Finance Ltd, the lending and investment arm of Bajaj Finserv, has increased the rate of interest of its fixed deposits, with effect from October 17, 2018. For the existing loan and FD customers, the rates have been hiked up to 9% and for new customers, up to 8.75%. Similarly, for senior citizens, the rates have been increased up to 9.10%. The new rates, valid for deposits up to Rs 5 crore, are offered on an annual basis, applicable under the cumulative and non-cumulative payout schemes on a 36-60 months’ tenor.
BAJAJFINSV BAJFINANCE 532978 BJJQY 500034

5
Sensex could top 44,000 after general elections; 7 buy ideas could return 20-90%

2018-10-16 moneycontrol
The Sensex is poised to touch 36,000-36,500 in the near-term and eventually go up to 44,000 after general elections 2019, Nalin Shah, Director at NVS Brokerage said in an interview to Moneycontrol's Sunil Shankar Matkar.
TVSMOTOR KMBKY JTEKY 532978 STRTECH SRLRY JTEKF 532343 BAJAJFINSV BAJFINANCE 532374 HDB LICHSGFIN 500180 KOTAKBANK HDFCBANK BJJQY LHFLY 500247 500570 TATAMOTORS 500253 500034 TTM

 
Stock Picks of the Day | Nifty may be vulnerable in short term; 3 stocks likely to be in focus

2018-10-15 moneycontrol
The Indian equity market witnessed wild volatility in the last week, posting a third massive selloff in October. On October 11, the Nifty fell by 2.16 percent, following global selloff across equity markets.
BAJFINANCE BJJQY 500034

4
Big gainers of the week - HPCL, Yes Bank, Bajaj Finance, RIL top the charts

2018-10-13 moneycontrol
Bulls had almost everything going their way on Friday, as benchmarks shrugged off weakness coming in from global markets and saw one of the biggest one-day gains since May 2016. For the week ended on October 12, 2018, both Sensex and the Nifty gained 1-1.5 percent.
IOC 500325 RELIANCE HCTHY TTNQY 505200 532540 RIGD 532281 BJJQY 500570 ZEEL TATAMOTORS EICHERMOT RLNIY 500034 YESBANK ECQRY 532648 YYBKY 530965 BAJFINANCE ZEEEY HCLTECH 505537 TCS HINDPETRO 500104 TTM

 
Rs 99 only! These Nokia smartphones can be yours – Here are the terms and conditions of this offer

2018-10-12 financialexpress
Nokia has launched its Diwali offer which will allow customers to buy many mobile phones for just Rs 99. The offer period for this sale begins on October 1, 2018, and will go on till November 10, 2018. Nokia phones that will be available in this offer will be the Nokia 1, Nokia 2.1, Nokia 3.1 Plus, Nokia 5.1, Nokia 6.1, and Nokia 8 Sirocco. Nokia 3.1 Plus will be available from October 19, 2018.
BAJFINANCE 532938 CAPF BJJQY 500034

 
This Diwali Be Thoughtful and Gift Something Beyond Crackers

2018-10-12 freepressjournal.in
India is well-known for its vibrant and colorful culture, which is especially apparent during festivals. Diwali is one of the most revered festivals where the entire country lights up with multicolored diyas, cracker noises, gorgeous attires, enticing variety of sweets, and much more. It is believed that Diwali is a festival of light, thus bringing light into people’s lives.
BAJFINANCE BJJQY 500034

 
Max India stock jumps 6% after Bajaj Finance raises stake in company

2018-10-12 moneycontrol
Max India share price rallied 6.3 percent intraday Friday after non-banking finance company Bajaj Finance raised its stake in the company.
500271 BAJFINANCE BJJQY MAX MXGQY 500034

 
Day after rally, NBFCs caught in bear trap; Indiabulls Housing, DHFL top losers

2018-10-11 moneycontrol
Non-banking finance companies started bleeding again on Thursday after seeing a sharp rally in previous session due to report saying SBI will purchase loan assets worth up to Rs 45,000 crore from NBFCs.
535789 IBULHSGFIN BAJFINANCE IDKQY BJJQY 500034

 
Bajaj Finance gains as SBI aims to buy good quality NBFC assets

2018-10-10 thehindubusinessline
Shares of non-banking financial company (NBFC) Bajaj Finance rose sharply on Wednesday after SBI raised its target to buy “good quality” asset portfolios from NBFCs.
BAJFINANCE BHARATGEAR BJJQY 505688 500034

 
An evening walk down Dalal Street | Bulls rule D-Street as Sensex soars 461 points; Nifty above 10,450

2018-10-10 moneycontrol
Banking big on lenders, bulls went all guns blazing on D-Street on Tuesday as benchmark indices saw a good surge. Benchmarks ended over a percent higher; the Nifty soared past 10,450-mark.
INDIGO BHRYY GRAPHITE AXB 532617 JETAIRWAYS 532978 532215 539448 AXBKY AXBA BAJAJFINSV BAJFINANCE 534816 AXISBANK BJJQY INFRATEL 509488 500034 SBAZ

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...